125 related articles for article (PubMed ID: 27784345)
1. [Changes of ADAMTS13 Activity and TSP1 Level in Patients with Hematologic Malignancies].
Sun CF; Zhao X; Han F; Jia Q; Wang L; Lu G; Ding HF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1294-1298. PubMed ID: 27784345
[TBL] [Abstract][Full Text] [Related]
2. [Changes of ADAMTS13 activity and vWF antigen level in patients with acute myelogenous leukemia and their significance].
Zhang WJ; Han Y; Ma ZN; Wang Q; Tang YQ; Wang J; Su J; Sun AN; Wang ZY; Ruan CG; Wu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Dec; 22(6):1503-7. PubMed ID: 25543464
[TBL] [Abstract][Full Text] [Related]
3. [A study on the significance of plasma thrombospondin1 in thrombotic thrombocytopenic purpura and the relationship between thrombospondin1 and von Willebrand factor cleaving protease (ADAMTS13)].
Liu F; Lu GY; Dong NZ; Bai X; Su J; Ruan CG
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3190-3. PubMed ID: 16405838
[TBL] [Abstract][Full Text] [Related]
4. [ADAMTS13 Level in Prothrombotic Status and Its Related Factor Analysis].
Sun CF; Liu GQ; Zhao X; Han F; Xu M; Xing J; Liu J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Aug; 24(4):1125-31. PubMed ID: 27531787
[TBL] [Abstract][Full Text] [Related]
5. Thrombospondin-1 and ADAMTS13 competitively bind to VWF A2 and A3 domains in vitro.
Wang A; Liu F; Dong N; Ma Z; Zhang J; Su J; Zhao Y; Ruan C
Thromb Res; 2010 Oct; 126(4):e260-5. PubMed ID: 20705333
[TBL] [Abstract][Full Text] [Related]
6. Levels and activities of von Willebrand factor and metalloproteinase with thrombospondin type-1 motif, number 13 in inflammatory bowel diseases.
Cibor D; Owczarek D; Butenas S; Salapa K; Mach T; Undas A
World J Gastroenterol; 2017 Jul; 23(26):4796-4805. PubMed ID: 28765701
[TBL] [Abstract][Full Text] [Related]
7. Expression and significance of vWF, GMP-140 and ADAMTS13 in patients with aneurysmal subarachnoid hemorrhage.
Li WH; Hui CJ; Ju H
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(19):4350-4356. PubMed ID: 29077161
[TBL] [Abstract][Full Text] [Related]
8. [A clinical study of congenital thrombotic thrombocytopenic purpura].
Liu F; Dong NZ; Jin J; Hendrik FB; Bai X; Ruan CG
Zhonghua Nei Ke Za Zhi; 2006 Jun; 45(6):482-4. PubMed ID: 16831327
[TBL] [Abstract][Full Text] [Related]
9. [Correlation of serum ADAMTS13 and TSP1 levels with myocardial injury and prognosis in patients with acute coronary syndrome].
Yao Z; Bao B; Qian S; Li Z; Lu Q; Min S; Li M; Wang H
Nan Fang Yi Ke Da Xue Xue Bao; 2021 May; 41(5):710-715. PubMed ID: 34134958
[TBL] [Abstract][Full Text] [Related]
10. Serial changes in von Willebrand factor-cleaving protease (ADAMTS13) and prognosis after acute myocardial infarction.
Matsukawa M; Kaikita K; Soejima K; Fuchigami S; Nakamura Y; Honda T; Tsujita K; Nagayoshi Y; Kojima S; Shimomura H; Sugiyama S; Fujimoto K; Yoshimura M; Nakagaki T; Ogawa H
Am J Cardiol; 2007 Sep; 100(5):758-63. PubMed ID: 17719316
[TBL] [Abstract][Full Text] [Related]
11. Increased plasma von Willebrand factor antigen levels but normal von Willebrand factor cleaving protease (ADAMTS13) activity in preeclampsia.
Molvarec A; Rigó J; Bõze T; Derzsy Z; Cervenak L; Makó V; Gombos T; Udvardy ML; Hársfalvi J; Prohászka Z
Thromb Haemost; 2009 Feb; 101(2):305-11. PubMed ID: 19190814
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the Diagnostic Value of Plasma Levels, Activities, and Their Ratios of von Willebrand Factor and ADAMTS13 in Patients with Cerebral Infarction.
Qu L; Jiang M; Qiu W; Lu S; Zhao Y; Xia L; Ruan C; Zhao Y
Clin Appl Thromb Hemost; 2016 Apr; 22(3):252-9. PubMed ID: 25916953
[TBL] [Abstract][Full Text] [Related]
13. Molecular biology of ADAMTS13 and diagnostic utility of ADAMTS13 proteolytic activity and inhibitor assays.
Shelat SG; Ai J; Zheng XL
Semin Thromb Hemost; 2005 Dec; 31(6):659-72. PubMed ID: 16388417
[TBL] [Abstract][Full Text] [Related]
14. The clinical utility of ADAMTS13 activity, antigen and autoantibody assays in thrombotic thrombocytopenic purpura.
Starke R; Machin S; Scully M; Purdy G; Mackie I
Br J Haematol; 2007 Feb; 136(4):649-55. PubMed ID: 17367414
[TBL] [Abstract][Full Text] [Related]
15. Plasma ADAMTS13 activity and von Willebrand factor antigen and activity in patients with subarachnoid haemorrhage.
Kumar M; Cao W; McDaniel JK; Pham HP; Raju D; Nawalinski K; Frangos S; Kung D; Zager E; Kasner SE; Levine JM; Zheng XL
Thromb Haemost; 2017 Apr; 117(4):691-699. PubMed ID: 28102428
[TBL] [Abstract][Full Text] [Related]
16. [The association of von Willebrand factor and von Willebrand factor-cleaving protease in systemic lupus erythematosus].
Lu GY; Guo XF; Wang ZY; Bai X; Su J; Ruan CG
Zhonghua Nei Ke Za Zhi; 2006 Jan; 45(1):42-4. PubMed ID: 16624087
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of plasma von Willebrand factor and its cleaving protease ADAMTS13 in patients with atrial fibrillation.
Freynhofer MK; Gruber SC; Bruno V; Höchtl T; Farhan S; Zaller V; Wojta J; Huber K
Int J Cardiol; 2013 Sep; 168(1):317-25. PubMed ID: 23041092
[TBL] [Abstract][Full Text] [Related]
18. Significance of plasma von Willebrand factor level and von Willebrand factor-cleaving protease activity in patients with chronic renal diseases.
Lu GY; Shen L; Wang ZY; Guo XF; Bai X; Su J; Ruan CG
Chin Med J (Engl); 2008 Jan; 121(2):133-6. PubMed ID: 18272039
[TBL] [Abstract][Full Text] [Related]
19. Plasma ADAMTS13, von Willebrand Factor (VWF), and VWF Propeptide Profiles in Patients With Connective Tissue Diseases and Antiphospholipid Syndrome.
Habe K; Wada H; Matsumoto T; Ohishi K; Ikejiri M; Tsuda K; Kondo M; Kamimoto Y; Ikeda T; Katayama N; Mizutani H
Clin Appl Thromb Hemost; 2017 Sep; 23(6):622-630. PubMed ID: 26759371
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of plasma von Willebrand factor-cleaving protease (ADAMTS13) antigen levels in patients with coronary artery disease.
Miura M; Kaikita K; Matsukawa M; Soejima K; Fuchigami S; Miyazaki Y; Ono T; Uemura T; Tsujita K; Hokimoto S; Sumida H; Sugiyama S; Matsui K; Yamabe H; Ogawa H
Thromb Haemost; 2010 Mar; 103(3):623-9. PubMed ID: 20135067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]